Justin B. Klee, Co-Chief Executive Officer at Amylyx Pharmaceuticals, Inc. (AMLX), sold 7,715 shares at $11.09 ($86K) on 2026-01-06, disclosed to the SEC on 2026-01-08.
Seasonal sale ($86k) by Co-Chief Executive Officer — this insider has traded AMLX in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AMLX | SELL | 2026-02-04 | $228K | — | Filing → |
| AMLX | SELL | 2026-01-20 | $3.8M | — | Filing → |
| AMLX | SELL | 2025-10-02 | $859K | — | Filing → |